1 - small cell carcinoma of the lung 2 - acute monocytic and myelomonocytic leukaemia 3 - Hodgkins disease 4 - Non-Hodgkins lymphonia INDICATIONS AS AT 5 OCTOBER 2000: In the treatment of: 1. Small cell carcinoma of the lung. 2. Acute monocytic and myelomonocytic leukaemia. 3. Hodgkin's disease. 4. Non-Hodgkin's lymphoma.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
1 - small cell carcinoma of the lung 2 - acute monocytic and myelomonocytic leukaemia 3 - Hodgkins disease 4 - Non-Hodgkins lymphonia INDICATIONS AS AT 5 OCTOBER 2000: In the treatment of: 1. Small cell carcinoma of the lung. 2. Acute monocytic and myelomonocytic leukaemia. 3. Hodgkin's disease. 4. Non-Hodgkin's lymphoma.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on June 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
1 - small cell carcinoma of the lung 2 - acutre monocytic and myelomoncytic leukaemia 3 - Hodgkins disease 4 - Non-Hodgkins lymphoma INDICATIONS AS AT 5 OCTOBER 2000: In the treatment of: 1. Small cell carcinoma of the lung. 2. Acute monocytic and myelomonocytic leukaemia. 3. Hodgkin's disease. 4. Non-Hodgkin's lymphoma.
How to take it
The way to take this medicine is: Oral.
This medicine is taken by mouth.
Store below 25 degrees Celsius
Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on June 1, 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.